Alcoholic Liver Disease
Alcoholic Liver Disease
Alcohol consumption is an important social, economic, and health problem. Heavy alcohol consumption results in a wide range of multi-organ pathology, including alcoholic liver disease (ALD) which is a major cause of alcohol-related morbidity and mortality in the United States and Worldwide. The clinical spectrum of ALD ranges from fatty liver to alcoholic hepatitis, fibrosis and cirrhosis, which may progress even further to hepatocellular carcinoma. ALD has limited prevention and therapeutic options. Therefore, understanding the molecular mechanism(s) that mediate the development and progression of alcohol-induced liver pathology, as well as identifying new biomarkers, therapeutic targets and promising novel therapeutic agents to prevent, manage, or reverse the disease progression, is of paramount importance.
We welcome contributions on the pathogenesis and treatment options for alcoholic liver disease that are currently available or in the pipe-line. We are soliciting contributions from experts in the field of hepatology, pathology, epidemiology, genetics, biochemistry, pharmacology, molecular biology to provide new information on the roles of diverse factors (genetic polymorphisms, drinking pattern, gender, epigenetic changes, alterations in methionine metabolism, cellular communications, dietary habits, intestinal dysbiosis, adipose dysfunction, viral/bacterial infections) that can promote the pathogenesis and progression of ALD as well as data on new biomarkers and their implications for diagnosis and therapy for ALD.
Potential topics include but not limited to the following:
- Pathogenesis of Alcoholic Liver Disease
- Spectrum of Alcoholic Liver Disease
- Alcoholic Hepatitis
- Cell- to-cell Communications within Liver in ALD progression
- Role of other organs in ALD progression/Organ-organ Interplay
- Second Hits in ALD progression (Metabolic syndrome, Bacterial/Viral/Drugs)
- Treatment Options
Types of Manuscripts
- Review Articles
- Original Research
- Short -Communications
- Clinical Studies
How we work:
After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days. A 21 day window time frame is allotted for peer-review process wherein multiple experts are contacted. Author proof is generated within 7 working days after the acceptance decision.
Benefits on Publication:
Open Access: Permanent free access to your article upon publication ensures extensive global reach and readership.
Easy Article Sharing: Our open access enables you to share your article directly with colleagues through email and on social media via a single link, permitting third party reuse with appropriate citation in addition to the retention of content copyright by the author.
Global Marketing: Through promotion in a targeted global email announcement or press release, your article will be seen by thousands of the top-most thought-leaders in your field.
Social Media Exposure: Extended reach for your article through links on Twitter accounts provides maximum visibility worldwide.
Reprints: Distribute your work to colleagues and at conferences as we provide hard copy color reprints of your article on order.
Journal of Medical and surgical pathology